Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

For the past ten years, Pharmicell Co., Ltd has devoted itself to the development of stem cell therapeutics for incurable diseases. Pharmicell’s unceasing efforts and dedication in stem cell therapeutic research gained NDA approval from the KFDA in 2011. Since then, the world’s first stem cell therapeutics has been successfully launched. It is well known that stem cell therapeutics has been used to treat rare and incurable...
For the past ten years, Pharmicell Co., Ltd has devoted itself to the development of stem cell therapeutics for incurable diseases. Pharmicell’s unceasing efforts and dedication in stem cell therapeutic research gained NDA approval from the KFDA in 2011. Since then, the world’s first stem cell therapeutics has been successfully launched. It is well known that stem cell therapeutics has been used to treat rare and incurable diseases. Pharmicell has focused on stem cell therapeutics to treat various diseases using bone marrow-derived mesenchymal stem cells and peripheral blood-derived hematopoietic stem cells.

List your booth number for exhibitions, ask us